Skip to content

GABAergic involvement in conscious perception

GABAergic involvement in conscious perception - GABA and conscious perception

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57473
Enrollment
160
Registered
2024-03-12
Start date
2025-12-02
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not applicable NA

Interventions

Participants will receive 1.5 mg lorazepam or placebo on two different test sessions, in a randomized order.

Sponsors

Universiteit van Amsterdam
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers between 18 and 30 years old; BMI between 18.5 and 30.

Exclusion criteria

Exclusion criteria: Allergy for lorazepam, or one of the inactive ingredients of these  products; Current or history of any medical or psychiatric disorder or disease.

Design outcomes

Primary

MeasureTime frame
Primary study parameters include behavioral reaction times and performance scores, eye-tracking and EEG- and fMRI-measures.

Countries

Netherlands

Contacts

Public ContactS van Gaal

Universiteit van Amsterdam

s.vangaal@uva.nl+31205256711

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)